

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 7.67686317 |
| 2 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.73231484 |
| 3 | regulation of T cell tolerance induction (GO:0002664) | 6.52113552 |
| 4 | negative thymic T cell selection (GO:0045060) | 6.50317035 |
| 5 | positive regulation of tolerance induction (GO:0002645) | 6.24807632 |
| 6 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.18108161 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.17564249 |
| 8 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.13325803 |
| 9 | regulation of regulatory T cell differentiation (GO:0045589) | 5.99314649 |
| 10 | regulation of T cell chemotaxis (GO:0010819) | 5.98527274 |
| 11 | positive regulation of T cell chemotaxis (GO:0010820) | 5.98527274 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 5.93583430 |
| 13 | cytidine metabolic process (GO:0046087) | 5.72191049 |
| 14 | cytidine catabolic process (GO:0006216) | 5.72191049 |
| 15 | cytidine deamination (GO:0009972) | 5.72191049 |
| 16 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.44852778 |
| 17 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.44852778 |
| 18 | thymic T cell selection (GO:0045061) | 5.42623385 |
| 19 | regulation of tolerance induction (GO:0002643) | 5.36319034 |
| 20 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.29889764 |
| 21 | positive T cell selection (GO:0043368) | 5.26793966 |
| 22 | regulation of activation of Janus kinase activity (GO:0010533) | 5.23503642 |
| 23 | activated T cell proliferation (GO:0050798) | 5.23384151 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.17129120 |
| 25 | T cell selection (GO:0045058) | 5.01599065 |
| 26 | response to interleukin-15 (GO:0070672) | 4.97252510 |
| 27 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.92791758 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91072442 |
| 29 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.79790668 |
| 30 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.67041679 |
| 31 | positive regulation of cell killing (GO:0031343) | 4.65800407 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 4.62740300 |
| 33 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.61976567 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50939958 |
| 35 | DNA deamination (GO:0045006) | 4.49675566 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.47810113 |
| 37 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.46277967 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.43664250 |
| 39 | positive thymic T cell selection (GO:0045059) | 4.39753329 |
| 40 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.37944352 |
| 41 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.37029670 |
| 42 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.25683278 |
| 43 | T cell receptor signaling pathway (GO:0050852) | 4.20110263 |
| 44 | regulation of cell killing (GO:0031341) | 4.16844896 |
| 45 | interferon-gamma production (GO:0032609) | 4.05099899 |
| 46 | cellular defense response (GO:0006968) | 4.03712066 |
| 47 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.01788812 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96237903 |
| 49 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.94795624 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.94329913 |
| 51 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.90426332 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.88603573 |
| 53 | T cell costimulation (GO:0031295) | 3.84211337 |
| 54 | T cell mediated immunity (GO:0002456) | 3.83923214 |
| 55 | T cell migration (GO:0072678) | 3.81711351 |
| 56 | lymphocyte costimulation (GO:0031294) | 3.81229253 |
| 57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.77311054 |
| 58 | positive regulation of T cell migration (GO:2000406) | 3.76471608 |
| 59 | positive regulation of humoral immune response (GO:0002922) | 3.68061212 |
| 60 | lymphocyte chemotaxis (GO:0048247) | 3.66624607 |
| 61 | actin nucleation (GO:0045010) | 3.65193056 |
| 62 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.58984962 |
| 63 | signal complex assembly (GO:0007172) | 3.58303265 |
| 64 | positive regulation of lymphocyte migration (GO:2000403) | 3.58010988 |
| 65 | regulation of macrophage chemotaxis (GO:0010758) | 3.55696710 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.53742567 |
| 67 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.53181788 |
| 68 | negative regulation of cell killing (GO:0031342) | 3.52570057 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52570057 |
| 70 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.51979007 |
| 71 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.48838660 |
| 72 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.47285272 |
| 73 | dendritic cell chemotaxis (GO:0002407) | 3.43014003 |
| 74 | positive regulation of interleukin-4 production (GO:0032753) | 3.40688292 |
| 75 | regulation of immune response to tumor cell (GO:0002837) | 3.38540920 |
| 76 | regulation of response to tumor cell (GO:0002834) | 3.38540920 |
| 77 | positive regulation of response to tumor cell (GO:0002836) | 3.38540920 |
| 78 | positive regulation of immune response to tumor cell (GO:0002839) | 3.38540920 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 3.38014668 |
| 80 | negative regulation of viral genome replication (GO:0045071) | 3.34552196 |
| 81 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33933329 |
| 82 | chemokine-mediated signaling pathway (GO:0070098) | 3.30051110 |
| 83 | positive regulation of granulocyte differentiation (GO:0030854) | 3.28874943 |
| 84 | lymphocyte migration (GO:0072676) | 3.27210422 |
| 85 | positive regulation of interleukin-17 production (GO:0032740) | 3.25719008 |
| 86 | negative regulation of T cell apoptotic process (GO:0070233) | 3.25517930 |
| 87 | regulation of T cell migration (GO:2000404) | 3.25304800 |
| 88 | leukocyte aggregation (GO:0070486) | 3.24199291 |
| 89 | T cell apoptotic process (GO:0070231) | 3.17137718 |
| 90 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09880384 |
| 91 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.06321818 |
| 92 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.05017073 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 3.04480071 |
| 94 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.03717957 |
| 95 | negative regulation of B cell activation (GO:0050869) | 3.01148651 |
| 96 | regulation of mononuclear cell migration (GO:0071675) | 3.01095469 |
| 97 | T cell proliferation (GO:0042098) | 3.00950037 |
| 98 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.00771522 |
| 99 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00048625 |
| 100 | eosinophil chemotaxis (GO:0048245) | 2.96657997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.50596079 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.37633058 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.74943242 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.30811054 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.29308902 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.54735126 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.29301504 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.27312040 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.23248699 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.11580668 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.11134583 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.96627431 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84704666 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.56732097 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.33286677 |
| 16 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.26278952 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.24297232 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21236893 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.11532386 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.08727526 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05625638 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 1.98890328 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93109985 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.81782252 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76533176 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70288333 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.65216405 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.64025094 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.63982228 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.63276944 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62108744 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.57664672 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.54735885 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46152822 |
| 35 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44418981 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43101452 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41200102 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40067940 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35594158 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33525134 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27863288 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27054519 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24473446 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20379718 |
| 45 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16361870 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15617425 |
| 47 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.14113336 |
| 48 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14047355 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07043176 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05217136 |
| 51 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01149230 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98162483 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96435647 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93435833 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93349229 |
| 56 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.91635161 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90492674 |
| 58 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.89154644 |
| 59 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87760319 |
| 60 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86952839 |
| 61 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.86567311 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86128291 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85806896 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85531942 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84876013 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84317925 |
| 67 | GATA3_26560356_Chip-Seq_TH1_Human | 0.84294874 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83814754 |
| 69 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83259042 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82846201 |
| 71 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82374438 |
| 72 | P300_27268052_Chip-Seq_Bcells_Human | 0.77805884 |
| 73 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.77310907 |
| 74 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.74814062 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74608108 |
| 76 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.73900399 |
| 77 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.73868495 |
| 78 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.73692641 |
| 79 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.73249649 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72961635 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.72872321 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72270145 |
| 83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.72209378 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.68456841 |
| 85 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.67443558 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.67301051 |
| 87 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.66924154 |
| 88 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66887834 |
| 89 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.65690203 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.64836420 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.64296600 |
| 92 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.64191549 |
| 93 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.63350094 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.62955546 |
| 95 | ERA_21632823_ChIP-Seq_H3396_Human | 0.62774702 |
| 96 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.62595494 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.62481772 |
| 98 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61773032 |
| 99 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.61354370 |
| 100 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.60911846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.12418433 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.80054373 |
| 3 | MP0009333_abnormal_splenocyte_physiolog | 3.42861617 |
| 4 | MP0009785_altered_susceptibility_to | 3.38038927 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.37672338 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.26048559 |
| 7 | MP0002163_abnormal_gland_morphology | 3.24546899 |
| 8 | MP0000685_abnormal_immune_system | 3.09143760 |
| 9 | MP0001800_abnormal_humoral_immune | 2.99225228 |
| 10 | MP0005387_immune_system_phenotype | 2.77532037 |
| 11 | MP0001790_abnormal_immune_system | 2.77532037 |
| 12 | MP0002723_abnormal_immune_serum | 2.76884968 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.74020267 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.71233039 |
| 15 | MP0001819_abnormal_immune_cell | 2.68860548 |
| 16 | MP0005025_abnormal_response_to | 2.58231747 |
| 17 | MP0001348_abnormal_lacrimal_gland | 2.52518876 |
| 18 | MP0005310_abnormal_salivary_gland | 2.47873532 |
| 19 | MP0003866_abnormal_defecation | 2.39526292 |
| 20 | MP0002006_tumorigenesis | 2.39362695 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.37572727 |
| 22 | MP0003436_decreased_susceptibility_to | 2.37359884 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.34157963 |
| 24 | MP0001873_stomach_inflammation | 2.33197382 |
| 25 | MP0002398_abnormal_bone_marrow | 2.32438788 |
| 26 | MP0005451_abnormal_body_composition | 2.32415628 |
| 27 | MP0006082_CNS_inflammation | 2.30418677 |
| 28 | MP0000716_abnormal_immune_system | 2.03877275 |
| 29 | MP0001346_abnormal_lacrimal_gland | 1.96142219 |
| 30 | MP0005379_endocrine/exocrine_gland_phen | 1.94901838 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.94309789 |
| 32 | MP0002419_abnormal_innate_immunity | 1.94121851 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.93067304 |
| 34 | MP0002405_respiratory_system_inflammati | 1.91106561 |
| 35 | MP0004381_abnormal_hair_follicle | 1.90841350 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.76612365 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.75401438 |
| 38 | MP0004947_skin_inflammation | 1.70956738 |
| 39 | MP0002722_abnormal_immune_system | 1.66886540 |
| 40 | MP0003045_fibrosis | 1.61903648 |
| 41 | MP0002429_abnormal_blood_cell | 1.59498661 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.55260019 |
| 43 | MP0002102_abnormal_ear_morphology | 1.49561326 |
| 44 | MP0003448_altered_tumor_morphology | 1.39995923 |
| 45 | MP0001853_heart_inflammation | 1.38566221 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.37592510 |
| 47 | MP0003646_muscle_fatigue | 1.36580794 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.31403785 |
| 49 | MP0008872_abnormal_physiological_respon | 1.30512082 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.28190052 |
| 51 | MP0002933_joint_inflammation | 1.23013713 |
| 52 | MP0008469_abnormal_protein_level | 1.19428611 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.16238069 |
| 54 | MP0002822_catalepsy | 1.16132128 |
| 55 | MP0003786_premature_aging | 1.14944160 |
| 56 | MP0000372_irregular_coat_pigmentation | 1.11902918 |
| 57 | MP0003724_increased_susceptibility_to | 1.09263610 |
| 58 | MP0002693_abnormal_pancreas_physiology | 1.09020192 |
| 59 | MP0009763_increased_sensitivity_to | 1.04245835 |
| 60 | MP0009764_decreased_sensitivity_to | 0.98563367 |
| 61 | MP0002009_preneoplasia | 0.97762616 |
| 62 | MP0008961_abnormal_basal_metabolism | 0.97525366 |
| 63 | MP0001533_abnormal_skeleton_physiology | 0.94391711 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 0.93756577 |
| 65 | MP0001968_abnormal_touch/_nociception | 0.88414224 |
| 66 | MP0001919_abnormal_reproductive_system | 0.87079171 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.83339243 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.74170680 |
| 69 | MP0008995_early_reproductive_senescence | 0.68436689 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 0.66727790 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.65198584 |
| 72 | MP0001663_abnormal_digestive_system | 0.59217323 |
| 73 | MP0004145_abnormal_muscle_electrophysio | 0.58984761 |
| 74 | MP0008877_abnormal_DNA_methylation | 0.58667378 |
| 75 | MP0002736_abnormal_nociception_after | 0.57308524 |
| 76 | MP0005083_abnormal_biliary_tract | 0.55914724 |
| 77 | MP0000858_altered_metastatic_potential | 0.50155729 |
| 78 | MP0000427_abnormal_hair_cycle | 0.49360339 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 0.49064036 |
| 80 | MP0009643_abnormal_urine_homeostasis | 0.47510211 |
| 81 | MP0003137_abnormal_impulse_conducting | 0.46181872 |
| 82 | MP0005389_reproductive_system_phenotype | 0.45944358 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.45291311 |
| 84 | MP0000604_amyloidosis | 0.45068615 |
| 85 | MP0002638_abnormal_pupillary_reflex | 0.45005612 |
| 86 | MP0000920_abnormal_myelination | 0.44858160 |
| 87 | MP0000609_abnormal_liver_physiology | 0.43890387 |
| 88 | MP0004043_abnormal_pH_regulation | 0.43673652 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.42135787 |
| 90 | MP0000613_abnormal_salivary_gland | 0.42124753 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.40247134 |
| 92 | MP0005253_abnormal_eye_physiology | 0.39795220 |
| 93 | MP0003011_delayed_dark_adaptation | 0.37970911 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.36968419 |
| 95 | MP0010307_abnormal_tumor_latency | 0.36172585 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.35766023 |
| 97 | MP0001191_abnormal_skin_condition | 0.35320334 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.33534096 |
| 99 | MP0005166_decreased_susceptibility_to | 0.33489802 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.33093482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 7.83653015 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.09611548 |
| 3 | T lymphocytopenia (HP:0005403) | 6.77468767 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 6.48438939 |
| 5 | Optic neuritis (HP:0100653) | 6.48438939 |
| 6 | IgG deficiency (HP:0004315) | 6.26351024 |
| 7 | Orchitis (HP:0100796) | 5.69546960 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 5.64360216 |
| 9 | Myositis (HP:0100614) | 5.44121164 |
| 10 | Encephalitis (HP:0002383) | 5.35738176 |
| 11 | Abnormality of T cells (HP:0002843) | 4.88364861 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 4.68329180 |
| 13 | Stomatitis (HP:0010280) | 4.52801454 |
| 14 | Keratoconjunctivitis (HP:0001096) | 4.48581927 |
| 15 | Pulmonary infiltrates (HP:0002113) | 4.39328513 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.38310184 |
| 17 | Abnormality of eosinophils (HP:0001879) | 4.14279767 |
| 18 | Eosinophilia (HP:0001880) | 3.99551270 |
| 19 | Joint swelling (HP:0001386) | 3.98410615 |
| 20 | Hypoproteinemia (HP:0003075) | 3.92168875 |
| 21 | Chronic diarrhea (HP:0002028) | 3.78402914 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 3.75333670 |
| 23 | Meningitis (HP:0001287) | 3.60647456 |
| 24 | Gangrene (HP:0100758) | 3.51390190 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.48176478 |
| 26 | Granulocytopenia (HP:0001913) | 3.48089791 |
| 27 | Keratitis (HP:0000491) | 3.42057107 |
| 28 | Hemoptysis (HP:0002105) | 3.39143537 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.31259508 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.28959491 |
| 31 | Acute hepatic failure (HP:0006554) | 3.28846604 |
| 32 | Hypergammaglobulinemia (HP:0010702) | 3.20458740 |
| 33 | Pustule (HP:0200039) | 3.16621455 |
| 34 | Leukocytosis (HP:0001974) | 3.14556264 |
| 35 | Aplastic anemia (HP:0001915) | 3.13261409 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.02054044 |
| 37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.95918109 |
| 38 | Vasculitis (HP:0002633) | 2.94795820 |
| 39 | Pulmonary embolism (HP:0002204) | 2.89457592 |
| 40 | Combined immunodeficiency (HP:0005387) | 2.85951094 |
| 41 | IgA deficiency (HP:0002720) | 2.83841325 |
| 42 | Thyroiditis (HP:0100646) | 2.83453779 |
| 43 | IgM deficiency (HP:0002850) | 2.82684346 |
| 44 | Congenital stationary night blindness (HP:0007642) | 2.81290062 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.80359694 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80019356 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80019356 |
| 48 | Recurrent viral infections (HP:0004429) | 2.72844049 |
| 49 | Anorexia (HP:0002039) | 2.71254763 |
| 50 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.65174379 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57707022 |
| 52 | Arterial thrombosis (HP:0004420) | 2.56219285 |
| 53 | Hypochromic anemia (HP:0001931) | 2.51266104 |
| 54 | Recurrent bronchitis (HP:0002837) | 2.50158206 |
| 55 | Abnormality of the pleura (HP:0002103) | 2.48658091 |
| 56 | Pancytopenia (HP:0001876) | 2.47191550 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.45262612 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.34741281 |
| 59 | Abnormal albumin level (HP:0012116) | 2.33049507 |
| 60 | Hypoalbuminemia (HP:0003073) | 2.33049507 |
| 61 | Glomerulopathy (HP:0100820) | 2.27697011 |
| 62 | Lymphopenia (HP:0001888) | 2.26626817 |
| 63 | Hypoplasia of the thymus (HP:0000778) | 2.21714486 |
| 64 | Polyneuropathy (HP:0001271) | 2.21228701 |
| 65 | Pancreatitis (HP:0001733) | 2.19509183 |
| 66 | Lymphoma (HP:0002665) | 2.15842152 |
| 67 | Abnormality of the pericardium (HP:0001697) | 2.13040434 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.03871036 |
| 69 | Eczematoid dermatitis (HP:0000976) | 2.03576171 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02046086 |
| 71 | Obstructive lung disease (HP:0006536) | 2.02046086 |
| 72 | Oral leukoplakia (HP:0002745) | 2.01592719 |
| 73 | Agammaglobulinemia (HP:0004432) | 2.00347718 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.00267378 |
| 75 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.00267378 |
| 76 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97896391 |
| 77 | Radial bowing (HP:0002986) | 1.94884234 |
| 78 | Renal cortical cysts (HP:0000803) | 1.94458109 |
| 79 | Thrombophlebitis (HP:0004418) | 1.94268612 |
| 80 | Cellular immunodeficiency (HP:0005374) | 1.85042923 |
| 81 | Chest pain (HP:0100749) | 1.81647565 |
| 82 | Loss of speech (HP:0002371) | 1.79624635 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 1.78720937 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78690248 |
| 85 | Skin rash (HP:0000988) | 1.77295300 |
| 86 | Vertigo (HP:0002321) | 1.77033502 |
| 87 | Recurrent skin infections (HP:0001581) | 1.76601820 |
| 88 | Recurrent abscess formation (HP:0002722) | 1.76333186 |
| 89 | Mitochondrial inheritance (HP:0001427) | 1.73526945 |
| 90 | Increased muscle lipid content (HP:0009058) | 1.73290559 |
| 91 | Ureteral stenosis (HP:0000071) | 1.68265553 |
| 92 | Ureteral obstruction (HP:0006000) | 1.66475417 |
| 93 | Papilloma (HP:0012740) | 1.66082897 |
| 94 | Verrucae (HP:0200043) | 1.66082897 |
| 95 | Recurrent bacterial skin infections (HP:0005406) | 1.64506508 |
| 96 | Abnormality of the renal cortex (HP:0011035) | 1.63726307 |
| 97 | Acute necrotizing encephalopathy (HP:0006965) | 1.60164796 |
| 98 | Paresthesia (HP:0003401) | 1.59258843 |
| 99 | Acne (HP:0001061) | 1.55189526 |
| 100 | Stenosis of the external auditory canal (HP:0000402) | 1.54968182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 8.33126514 |
| 2 | KDR | 3.89261620 |
| 3 | MAP4K1 | 3.25758862 |
| 4 | ITK | 2.85295146 |
| 5 | TGFBR2 | 2.82184500 |
| 6 | EPHB1 | 2.81148919 |
| 7 | MAP2K6 | 2.78603079 |
| 8 | BCR | 2.60924738 |
| 9 | GRK6 | 2.17177811 |
| 10 | GRK7 | 2.02291715 |
| 11 | FES | 1.95633653 |
| 12 | CAMKK2 | 1.95369746 |
| 13 | BTK | 1.91619018 |
| 14 | CLK1 | 1.91423675 |
| 15 | CSK | 1.84491199 |
| 16 | EPHA3 | 1.83663890 |
| 17 | TEC | 1.75784580 |
| 18 | PASK | 1.73235156 |
| 19 | NME1 | 1.66017882 |
| 20 | TLK1 | 1.53068008 |
| 21 | LCK | 1.50784653 |
| 22 | MAP3K11 | 1.49056161 |
| 23 | NLK | 1.48690940 |
| 24 | TESK2 | 1.48340836 |
| 25 | MAPKAPK3 | 1.45200060 |
| 26 | SYK | 1.42647746 |
| 27 | ADRBK2 | 1.32530944 |
| 28 | IKBKB | 1.31386341 |
| 29 | NEK6 | 1.27956983 |
| 30 | MARK3 | 1.27696848 |
| 31 | VRK2 | 1.26633807 |
| 32 | ACVR1B | 1.24158112 |
| 33 | CAMKK1 | 1.24153655 |
| 34 | MAP3K14 | 1.18793925 |
| 35 | PRKCQ | 1.13296024 |
| 36 | DAPK2 | 1.13001219 |
| 37 | FGFR4 | 1.09327903 |
| 38 | IKBKE | 1.05634863 |
| 39 | LYN | 0.98625451 |
| 40 | JAK3 | 0.92663331 |
| 41 | TSSK6 | 0.92047219 |
| 42 | PIM1 | 0.89944839 |
| 43 | SIK3 | 0.87523578 |
| 44 | WNK4 | 0.85209122 |
| 45 | JAK2 | 0.84502117 |
| 46 | STK10 | 0.83554275 |
| 47 | HCK | 0.82109868 |
| 48 | MAPK11 | 0.80654234 |
| 49 | TAOK1 | 0.79709534 |
| 50 | MST4 | 0.76835731 |
| 51 | JAK1 | 0.73707788 |
| 52 | ZAP70 | 0.73696626 |
| 53 | GRK1 | 0.65853872 |
| 54 | TAOK3 | 0.64938711 |
| 55 | TBK1 | 0.62698961 |
| 56 | FYN | 0.61616590 |
| 57 | GRK5 | 0.61278815 |
| 58 | IRAK1 | 0.59385440 |
| 59 | MAPKAPK2 | 0.56614042 |
| 60 | DAPK1 | 0.55387346 |
| 61 | FRK | 0.55119494 |
| 62 | NUAK1 | 0.54124101 |
| 63 | FGFR3 | 0.52143594 |
| 64 | NEK9 | 0.51360957 |
| 65 | TYK2 | 0.49469679 |
| 66 | PDK1 | 0.47480529 |
| 67 | MAP3K7 | 0.47258981 |
| 68 | TRPM7 | 0.46461626 |
| 69 | FER | 0.46066143 |
| 70 | MELK | 0.44909677 |
| 71 | OXSR1 | 0.44352433 |
| 72 | BCKDK | 0.43357518 |
| 73 | VRK1 | 0.43250869 |
| 74 | MAP3K13 | 0.42506550 |
| 75 | STK11 | 0.38517940 |
| 76 | CDK6 | 0.38327916 |
| 77 | PTK2B | 0.36048429 |
| 78 | IGF1R | 0.35819567 |
| 79 | ALK | 0.35293465 |
| 80 | PRKCD | 0.31752186 |
| 81 | IRAK4 | 0.31232386 |
| 82 | CDK4 | 0.29609080 |
| 83 | ZAK | 0.29146714 |
| 84 | TAOK2 | 0.28885729 |
| 85 | TYRO3 | 0.27802963 |
| 86 | RPS6KB2 | 0.26717522 |
| 87 | KIT | 0.26470399 |
| 88 | PAK4 | 0.23025063 |
| 89 | PRKCH | 0.22479602 |
| 90 | EIF2AK1 | 0.21587856 |
| 91 | RIPK4 | 0.21566706 |
| 92 | PRKCA | 0.21185478 |
| 93 | MAP3K12 | 0.20649142 |
| 94 | CAMK2A | 0.19514778 |
| 95 | HIPK2 | 0.16690668 |
| 96 | FGFR1 | 0.15996672 |
| 97 | PRKCB | 0.15734780 |
| 98 | MAP3K3 | 0.15574092 |
| 99 | LRRK2 | 0.15052835 |
| 100 | RPS6KA5 | 0.15010842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.33493477 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.61572597 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.41667136 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.38095674 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.25664034 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.24226862 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.11584153 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.93829913 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.91095248 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.79121352 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.74636416 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.56172382 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 2.41375541 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35395831 |
| 15 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.19835978 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78959732 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.67488678 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63940032 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56437548 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.45759514 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43153187 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.41872504 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.34403575 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33672411 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31776658 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24263274 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18011725 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09637950 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.02477011 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 1.02281867 |
| 31 | Asthma_Homo sapiens_hsa05310 | 0.96786937 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96714571 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95608327 |
| 34 | Ribosome_Homo sapiens_hsa03010 | 0.95337929 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90366910 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87125384 |
| 37 | Malaria_Homo sapiens_hsa05144 | 0.85900567 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 0.85206406 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83772961 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83759385 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 0.83231633 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 0.81551996 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78796940 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74694176 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.74044874 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73600919 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72850304 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71910428 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71857475 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69638605 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63691690 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.62675770 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61347566 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60160291 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58347853 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57155095 |
| 57 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56543780 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54766320 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52972286 |
| 60 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.51674061 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46686654 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.44858432 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42058578 |
| 64 | Protein export_Homo sapiens_hsa03060 | 0.41818967 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41544425 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.41474186 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40915048 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40411307 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39746759 |
| 70 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39407469 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.39263179 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.39011636 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38688825 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.38413778 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.37440615 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34949304 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34558785 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33067548 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32170448 |
| 80 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31558484 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29097152 |
| 82 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28908044 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.28358500 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26358583 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.26007385 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25002419 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24395099 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.24309746 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.23534021 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22337891 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20929197 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.20680906 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19133857 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.17228598 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16942736 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.16411711 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.16263370 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15582166 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12564565 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.11909204 |

